Last reviewed · How we verify
NCT04356456
A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Nutritional Supplement Lumenato and Its Impact on Skin Parameters in Healthy Female Subjects
NA trial testing Lumenato in Skin. Withdrawn.
30 June 2020
Quick facts
| Lead sponsor | LycoRed Ltd. |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | supportive care |
| Start date | 14 January 2020 |
| Primary completion | 30 June 2020 |
| Estimated completion | 8 August 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Lumenato
Conditions studied
- Skin — all drugs for Skin →
Sponsor
LycoRed Ltd.
Who can join
Adults 35 to 55, female only, with Skin. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate perceived changes in skin health and appearance after taking the study product daily for 12 weeks. The study product is a soft gel supplement containing tomato oil. cored Lumenato supplement on skin health and appearance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04356456
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lumenato
Trials testing the same drug.
- NCT05537350 — A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato · NA · completed
- NCT04248699 — Lumenato Nutritional Supplement on Skin Appearance · NA · completed
Other recruiting trials for Skin
Currently open trials in the same condition.
- NCT07298382 — See the Impact Beem's Blue Light Therapy Has on Your Skin Health! · NA · recruiting
- NCT07188948 — In Vivo Cross-Modal Imaging of Skin · recruiting
- NCT04305691 — Trial of Ixazomib for Kaposi Sarcoma · Phase 2 · recruiting
Other LycoRed Ltd. trials
Trials by the same sponsor.
- NCT05376501 — A Study to Evaluate the Effect of Astaxanthin in Healthy Participants · NA · completed
- NCT05537350 — A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato · NA · completed
- NCT05328388 — A Study to Evaluate the Effect of Lycomato on Skin Attributes in Healthy Participants. · NA · completed
- NCT04248699 — Lumenato Nutritional Supplement on Skin Appearance · NA · completed
- NCT03772808 — Effects of LycoComfort™ Supplementation on Symptoms Associated With Lower Urinary Tract Symptoms (LUTS) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04356456 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by LycoRed Ltd.
- Last refreshed: 13 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04356456.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing